EVGN: SEC Form 3 filed by Evogene Ltd
Stocks in this Quantisnow insightIndustrials
Full content unavailable. See the original source below.
Historical context for EVGN
Across the 29 sessions after earlier EVGN headlines, the stock closed higher 12 times and lower 17 times, with a median move of 2.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | EVGN | SPY |
|---|---|---|---|
| Oct 20, 2026 | Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL | +1.0% | +0.3% |
| Oct 7, 2026 | Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors | -3.1% | -0.2% |
| Sep 30, 2026 | Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance | -3.1% | -0.2% |
| Aug 31, 2026 | Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward | -2.4% | -0.3% |
| Aug 25, 2026 | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees | -1.7% | +0.3% |
| Aug 18, 2026 | Evogene Reports Second Quarter and First Half 2026 Financial Results | +4.0% | -0.7% |
Quantisnow market dataNASDAQ
EVGN
Evogene Ltd
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Agricultural Chemicals
Get push alerts for EVGN
Full EVGN profile on Quantisnow Follow EVGN and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time